Eyenovia Inc EYEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 07/01/22 EDT
1.90quote price arrow down-0.05 (-2.56%)
Volume
143,772
52 week range
1.61 - 6.63
Loading...
  • Open1.82
  • Day High1.95
  • Day Low1.81
  • Prev Close1.95
  • 52 Week High6.63
  • 52 Week High Date10/22/21
  • 52 Week Low1.61
  • 52 Week Low Date06/21/22

Key Stats

  • Market Cap63.78M
  • Shares Out33.57M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta2.05
  • YTD % Change-52.5

KEY STATS

  • Open1.82
  • Day High1.95
  • Day Low1.81
  • Prev Close1.95
  • 52 Week High6.63
  • 52 Week High Date10/22/21
  • 52 Week Low1.61
  • 52 Week Low Date06/21/22
  • Market Cap63.78M
  • Shares Out33.57M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta2.05
  • YTD % Change-52.5

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-3.53
  • Fwd P/E (NTM)-2.29
  • EBITDA (TTM)-14.479M
  • ROE (TTM)-70.43%
  • Revenue (TTM)12.00M
  • Gross Margin (TTM)93.33%
  • Net Margin (TTM)-123.05%
  • Debt To Equity (MRQ)25.98%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eyenovia Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Eyenovia, Inc. is a clinical-stage ophthalmic company. The Company is developing a pipeline of therapeutics based on its microdose array print (MAP) platform technology. Its pipeline is focused on the late-stage development of therapeutic indications for pediatric patients with progressive myopia in the United States and patients with age-related near vision impairment, or presbyopia indications. The Company is also developing the microdose fixed combination ophthalmic...
Tsontcho Ianchulev M.D.
Chairman of the Board, Chief Executive Officer, Chief Medical Officer
Michael Rowe
Chief Operating Officer
John Gandolfo
Chief Financial Officer, Secretary
Jennifer Clasby
Vice President - Clinical Operations
Address
295 Madison Ave Ste 2400
New York, NY
10017
United States

Top Peers

SYMBOLLASTCHG%CHG
TCRX
TScan Therapeutics Inc
3.20+0.06+1.75%
SLDB
Solid Biosciences Inc
0.576-0.0396-6.4327%
ALGS
Aligos Therapeutics Inc
1.25+0.04+3.31%
VTVT
vTv Therapeutics Inc
0.7203-0.0297-3.96%
LYRA
Lyra Therapeutics Inc
5.39-0.26-4.60%